Rhode Island Chronicle

Neurofibromatosis Market Insights, Epidemiology, and Market Forecast – 2030

 Breaking News
  • No posts were found

Neurofibromatosis Market Insights, Epidemiology, and Market Forecast – 2030

April 08
08:38 2020
Neurofibromatosis Market Insights, Epidemiology, and Market Forecast - 2030

DelveInsight has launched a new report on Neurofibromatosis Market Insights, Epidemiology, and Market Forecast-2030

DelveInsight’s “Neurofibromatosis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Neurofibromatosis , historical and forecasted epidemiology as well as the Neurofibromatosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Neurofibromatosis market report provides current treatment practices, emerging drugs, Neurofibromatosis market share of the individual therapies, current and forecasted Neurofibromatosis market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Neurofibromatosis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Neurofibromatosis (NF) is a rare genetic disorder that causes typically benign tumors of the nerves and growths in other parts of the body. Some people with this disorder have barely noticeable neurological problems, while others are affected profoundly. NF has been classified into three distinct types; NF1, NF2 and schwannomatosis.

 

Request for :- free sample page

Epidemiology

The Neurofibromatosis epidemiology division provide insights about historical and current Neurofibromatosis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Report Key facts:-

1. As per National Organization for Rare Disorders, NF1 is a rare disorder that affects males and females in equal numbers. NF1 affects all races and ethnic groups equally and is estimated to occur in 1 in 2,500 to 3,000 births.

2. According to the national institute of neurological disorder and stroke, NF1 is the most common neurofibromatosis, occurring in 1 in 3,000 to 4,000 individuals in the United States. Although many affected people inherit the disorder, between 30 and 50 percent of new cases result from a spontaneous genetic mutation of unknown cause. Once this mutation has taken place, the mutant gene can be passed to succeeding generations.

Key companies are working on disease that are given below:- 

1. AstraZeneca Pharma Co
2. Array Biopharma Co.
3. Springworks Therapeutics Co.

Name of drugs covered that are given below:- 

1. Selumetinib
2. Binimetinib
3. PD-0325901

Table of contents

1. Key Insights

2. Executive Summary of Neurofibromatosis

3. Competitive Intelligence Analysis for Neurofibromatosis

4. Neurofibromatosis : Market Overview at a Glance

4.1. Neurofibromatosis Total Market Share (%) Distribution in 2017

4.2. Neurofibromatosis Total Market Share (%) Distribution in 2030

5. Neurofibromatosis : Disease Background and Overview

6. Patient Journey

7. Neurofibromatosis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Neurofibromatosis Treatment and Management

8.2. Neurofibromatosis Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Neurofibromatosis Treatment

11. Marketed Products

12. Emerging Therapies

13. Neurofibromatosis : Seven Major Market Analysis

13.1. Key Findings

13.2. Neurofibromatosis Market Size in 7MM

13.3. Neurofibromatosis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Neurofibromatosis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Neurofibromatosis market
  • To understand the future market competition in the Neurofibromatosis market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Neurofibromatosis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Neurofibromatosis market
  • To understand the future market competition in the Neurofibromatosis market

Related Reports:- 

1. Neurofibromatosis – Epidemiology Forecast to 2030

2. Neurofibromatosis 2 – Pipeline Insights, 2020

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/